Veracyte Inc - ESG Rating & Company Profile powered by AI
This page displays a free Environmental, Social and Governance analysis covering Veracyte Inc. Other companies in the rating industry group for Veracyte Inc are displayed. The analysis of Veracyte Inc was prepared by All Street Sevva using leading artificial intelligence.
Veracyte Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 2.7, social score of 3.4 and governance score of 2.7.
2.9
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
1336 | Sensorion SA | 3.0 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1353 | Caribou Biosciences Inc | 2.9 | Medium |
1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Veracyte Inc have an accelerator or VC vehicle to help deliver innovation?
Does Veracyte Inc disclose current and historical energy intensity?
Does Veracyte Inc report the average age of the workforce?
Does Veracyte Inc reference operational or capital allocation in relation to climate change?
Does Veracyte Inc disclose its ethnicity pay gap?
Does Veracyte Inc disclose cybersecurity risks?
Does Veracyte Inc offer flexible work?
Does Veracyte Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Veracyte Inc disclose the number of employees in R&D functions?
Does Veracyte Inc conduct supply chain audits?
Does Veracyte Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Veracyte Inc conduct 360 degree staff reviews?
Does Veracyte Inc disclose the individual responsible for D&I?
Does Veracyte Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Veracyte Inc disclose current and / or historical scope 2 emissions?
Does Veracyte Inc disclose water use targets?
Does Veracyte Inc have careers partnerships with academic institutions?
Did Veracyte Inc have a product recall in the last two years?
Does Veracyte Inc disclose incidents of discrimination?
Does Veracyte Inc allow for Work Councils/Collective Agreements to be formed?
Has Veracyte Inc issued a profit warning in the past 24 months?
Does Veracyte Inc disclose parental leave metrics?
Does Veracyte Inc disclose climate scenario or pathway analysis?
Does Veracyte Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Veracyte Inc disclose the pay ratio of women to men?
Does Veracyte Inc support suppliers with sustainability related research and development?
Does Veracyte Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Veracyte Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Veracyte Inc involved in embryonic stem cell research?
Does Veracyte Inc disclose GHG and Air Emissions intensity?
Does Veracyte Inc disclose its waste policy?
Does Veracyte Inc report according to TCFD requirements?
Does Veracyte Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Veracyte Inc disclose energy use targets?
Does Veracyte Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Veracyte Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Veracyte Inc
These potential risks are based on the size, segment and geographies of the company.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.